Phage Therapy: Publications

Bacteriophage Ecology Group Bacteriophage Ecology Group

2011 Phage Therapy Publications

Ahiwale, S., N. Tamboli, K. Thorat, R. Kulkarni, H. Ackermann, and B. Kapadnis. 2011. In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage. Curr. Microbiol. 62:335-340. [PubMed]

Alam, M., M. Z. Akhter, M. Yasmin, C. R. Ahsan, and J. Nessa. 2011. Local bacteriophage isolates showed anti- Escherichia coli O157:H7 potency in an experimental ligated rabbit ileal loop model. Can. J. Microbiol. 57:408-415. [PubMed]

Alfadhel, M., U. Puapermpoonsiri, S. J. Ford, F. J. McInnes, and C. F. van der Walle. 2011. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation. Int. J Pharm. 416:280-287. [PubMed]

Anany, H., W. Chen, R. Pelton, and M. W. Griffiths. 2011. Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes. Appl. Environ. Microbiol. 77:6379-6387. [PubMed]

Burrowes, B., D. R. Harper, J. Anderson, M. McConville, and M. C. Enright. 2011. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti. Infect. Ther. 9:775-785. [PubMed] review

Callaway, T. R., T. S. Edrington, R. C. Anderson, J. A. Byrd, M. H. Kogut, R. B. Harvey, and D. J. Nisbet. 2011. Using antimicrobial cultures, bacteriocins and bacteriophages to reduce carriage of food-borne pathogens in cattle and swine, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review

Castillo-Ruiz, M., E. D. Vines, C. Montt, J. Fernandez, J. M. Delgado, J. C. Hormazabal, and M. Bittner. 2011. Isolation of a novel Aggregatibacter actinomycetemcomitans serotype b bacteriophage capable of lysing bacteria within a biofilm. Appl. Environ. Microbiol. 77:3157-3159. [PubMed]

Choi, J., S. M. Kotay, and R. Goel. 2011. Bacteriophage-based biocontrol of biological sludge bulking in wastewater. Bioeng. Bugs. 2:214-217. [PubMed]

Coffey, B., L. Rivas, G. Duffy, A. Coffey, R. P. Ross, and O. McAuliffe. 2011. Assessment of Escherichia coli O157:H7-specific bacteriophages e11/2 and e4/1c in model broth and hide environments. Int. J. Food Microbiol. 147:188-194. [PubMed]

Connerton, P. L., A. R. Timms, and I. F. Connerton. 2011. Campylobacter bacteriophages and bacteriophage therapy. J. Appl. Microbiol. 111:255-265. [PubMed]

Connerton, P. L., A. R. Timms, and I. F. Connerton. 2011. Using antimicrobial cultures, bacteriocins and bacteriophages to reduce carriage of foodborne bacterial pathogens in poultry, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. [PubMed] review

Cornelissen, A., P. J. Ceyssens, J. T'Syen, P. H. Van, J. P. Noben, O. V. Shaburova, V. N. Krylov, G. Volckaert, and R. Lavigne. 2011. The T7-related Pseudomonas putida phage phi15 displays virion-associated biofilm degradation properties. PLoS. One. 6:e18597.

Curtright, A. J. and S. T. Abedon. 2011. Phage therapy: emergent property pharmacology. J. Bioanal. Biomed. S6:002. [Publisher] [Local Link] review

Deasy, T., J. Mahony, H. Neve, K. J. Heller, and D. van Sinderen. 2011. Isolation of a virulent Lactobacillus brevis phage and its application in the control of beer spoilage. J Food Prot. 74:2157-2161. [PubMed]

Fazil, M. H. and D. V. Singh. 2011. Vibrio cholerae infection, novel drug targets and phage therapy. Future. Microbiol. 6:1199-1208. [PubMed] review

Fieseler, L. and M. J. Loessner. 2011. Bacteriophages and food safety, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review

Fujiwara, A., M. Fujisawa, R. Hamasaki, T. Kawasaki, M. Fujie, and T. Yamada. 2011. Biocontrol of Ralstonia solanacearum by treatment with lytic bacteriophages. Appl. Environ. Microbiol. [PubMed]

Gill, J. J. and R. Young. 2011. Therapeutic applications of phage biology: history, practice and recommendations, p. ???. In: A. A. Miller and P. F. Miller (eds.), Emerging Trends in Antibacterial Discovery: Answering the Call to Arms. Caister Academic Press, Norfolk,UK. [Publisher] review

Goodridge, L. D. and B. Bisha. 2011. Phage-based biocontrol strategies to reduce foodborne pathogens in foods. Bacteriophage 1:130-137. [PubMed] review

Guenther, S. and M. J. Loessner. 2011. Bacteriophage biocontrol of Listeria monocytogenes on soft ripened white mold and red-smear cheeses. Bacteriophage 1:94-100. [PubMed]

Harper, D. R. and M. C. Enright. 2011. Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J Appl. Microbiol. 111:1-7. [PubMed] review

Hooton, S. P., R. J. Atterbury, and I. F. Connerton. 2011. Application of a bacteriophage cocktail to reduce Salmonella Typhimurium U288 contamination on pig chicken skin. Int. J. Food Microbiol. 151:157-163. [PubMed]

Hung, C. H., C. F. Kuo, C. H. Wang, C. M. Wu, and N. Tsao. 2011. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob. Agents Chemother. 55:1358-1365. [PubMed]

Kelly, D., O. McAuliffe, R. P. Ross, J. O'Mahony, and A. Coffey. 2011. Development of a broad-host-range phage cocktail for biocontrol. Bioeng. Bugs. 2:31-37. [PubMed]

Khawaldeh, A., S. Morales, B. Dillon, Z. Alavidze, A. N. Ginn, L. Thomas, S. J. Chapman, A. Dublanchet, A. Smithyman, and J. R. Iredell. 2011. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. J Med. Microbiol. 60:1697-1700. [PubMed]

Knezevic, P., D. Obreht, S. Curcin, M. Petrusic, V. Aleksic, R. Kostanjsek, and O. Petrovic. 2011. Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation. J. Appl. Microbiol. 111:245-254. [PubMed]

Kotay, S. M., T. Datta, J. Choi, and R. Goel. 2011. Biocontrol of biomass bulking caused by Haliscomenobacter hydrossis using a newly isolated lytic bacteriophage. Water Res 45:694-704. [PubMed]

Kumari, S., K. Harjai, and S. Chhibber. 2011. Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med. Microbiol. 60:205-210. [PubMed]

Kvachadze, L., N. Balarjishvili, T. Meskhi, E. Tevdoradze, N. Skhirtladze, T. Pataridze, R. Adamia, T. Topuria, E. Kutter, C. Rohde, and M. Kutateladze. 2011. Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens. Microb. Biotechnol. ??? [PubMed]

Lim, T. H., D. H. Lee, Y. N. Lee, J. K. Park, H. N. Youn, M. S. Kim, H. J. Lee, S. Y. Yang, Y. W. Cho, J. B. Lee, S. Y. Park, I. S. Choi, and C. S. Song. 2011. Efficacy of bacteriophage therapy on horizontal transmission of Salmonella gallinarum on commercial layer chickens. Avian Dis. 55:435-438. [PubMed]

Loc-Carrillo, C. and S. T. Abedon. 2011. Pros and cons of phage therapy. Bacteriophage 1:111-114. [PubMed] [Local Link] review

Lu, T. K. and M. S. Koeris. 2011. The next generation of bacteriophage therapy. Curr Opin Microbiol. 14:524-531. review

Mahony, J., O. McAuliffe, R. P. Ross, and S. D. van. 2011. Bacteriophages as biocontrol agents of food pathogens. Curr Opin Biotechnol. 22:157-163. [PubMed] review

Maura, D., E. Morello, M. L. du, P. Bomme, B. C. Le, and L. Debarbieux. 2011. Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice. Environ. Microbiol. ??? [PubMed]

Medina, M. and M. Nuņez. 2011. Applications of protective cultures, bacteriocins and bacteriophages in milk and dairy products, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review

Moradpour, Z. and A. Ghasemian. 2011. Modified phages: Novel antimicrobial agents to combat infectious diseases. Biotechnol. Adv. 29:732-738 [PubMed]review

Morello, E., E. Saussereau, D. Maura, M. Huerre, L. Touqui, and L. Debarbieux. 2011. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 6:e16963. [PubMed]

Paul, V. D., S. Sundarrajan, S. S. Rajagopalan, S. Hariharan, N. Kempashanaiah, S. Padmanabhan, B. Sriram, and J. Ramachandran. 2011. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. BMC Microbiol. 11:195. [PubMed]

Pilet, M.-F. and F. Leroi. 2011. Applications of protective cultures, bacteriocins and bacteriophages in fresh seafood and seafood products, p. ???. In: C. Lacroix (ed.), Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Woodhead Publishing, Cambridge, UK. review

Pires, D., S. Sillankorva, A. Faustino, and J. Azeredo. 2011. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilm. Res. Microbiol. 162:798-806. [PubMed]

Pirnay, J. P., V. D. De, G. Verbeken, M. Merabishvili, N. Chanishvili, M. Vaneechoutte, M. Zizi, G. Laire, R. Lavigne, I. Huys, G. Van den Mooter, A. Buckling, L. Debarbieux, F. Pouillot, J. Azeredo, E. Kutter, A. Dublanchet, A. Górski, and R. Adamia. 2011. The phage therapy paradigm: prêt-à-porter or sur-mesure? ["Ready-to-wear or custom-made"] Pharm. Res. 28:934-937. [PubMed] review

Raya, R. R., R. A. Oot, B. Moore-Maley, S. Wieland, T. R. Callaway, E. Kutter, and A. D. Brabban. 2011. Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts. Bacteriophage 1. [PubMed]

Ryan, E. M., S. P. Gorman, R. F. Donnelly, and B. F. Gilmore. 2011. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J. Pharm. Pharmacol. 63:1253-1264. [PubMed] review

Siringan, P., P. L. Connerton, R. J. Payne, and I. F. Connerton. 2011. Bacteriophage-mediated dispersal of Campylobacter jejuni biofilms. Appl. Environ. Microbiol. 77:3320-3326. [PubMed]

Tiwari, B. R., S. Kim, M. Rahman, and J. Kim. 2011. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models. J Microbiol. 49:994-999. [PubMed]

Tothova, L., P. Celec, J. Babickova, J. Gajdosova, H. Al-Alami, N. Kamodyova, H. Drahovska, A. Liptakova, J. Turna, and J. Hodosy. 2011. Phage therapy of Cronobacter-induced urinary tract infection in mice. Med. Sci. Monit. 17:BR173-BR178. [PubMed]

Volkel, I. and C. P. Czerny. 2011. [Phage therapy in the fields of veterinary medicine: an overview]. Berl Munch. Tierarztl. Wochenschr. 124:303-312. [PubMed] review

Return to Home or see Phage Terms/Glossary.

Contact web master.